Comparator products are essential in clinical drug research for assessing the efficacy and safety of new medicines.
Comparator products (control products or placebos) serve as a reference for assessing the effect of the investigational product. They enable researchers to assess the therapeutic effect of the new medicine compared to already established therapies or a neutral substance. Their use contributes to an accurate, objective, and reliable assessment of the efficacy of the investigational product.
Typically, comparator products are obtained from companies specializing in the provision of medicines for clinical trials. These companies ensure that the comparator products meet the quality requirements and specifications of the clinical trial. They work closely with research teams and sponsors to provide the appropriate comparator products in a timely manner.
The procurement of comparator products requires careful planning and coordination. Researchers must decide early on which comparator product is optimal for their study. This depends on various factors, including the type of disease or condition, the patient population to be studied, and ethical guidelines for the use of placebos. The exact quantity and dosage of the comparator product are also determined to ensure the correct conduct of the study.
Before conducting a clinical trial, an application must be submitted to the competent ethics committees and the competent authorities. These applications contain detailed information about the planned study, including the planned use of comparator products. Approval is granted after a comprehensive review of the ethical and legal aspects of the study.
To ensure the safety of study participants, it is of utmost importance that the procurement of comparator products complies with strict regulations and quality standards. The suppliers of these products are subject to strict control mechanisms and quality assurance processes to ensure that the comparator products meet regulatory and quality requirements.
If you have further questions or need additional information on the procurement of comparator products for clinical trials, we are happy to help you.
In the field of clinical research, two identification numbers play a central role: the EudraCT number and the NCT number.
Comparator products are essential in clinical trials for assessing the efficacy and safety of new medicines.
Certificates of Analysis (CoA), Certificates of Origin (CoO), and Certificates of Conformity (CoC) play an important role in ensuring quality, origin, and conformity.
Parallel imports play a central role in ensuring access to affordable medicines and promoting competition in the market.
